Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer

  Free Subscription


11.05.2025

2 Acta Cytol
1 Acta Obstet Gynecol Scand
1 Ann Clin Lab Sci
1 Ann Epidemiol
1 Ann Rheum Dis
1 Apoptosis
1 Arch Biochem Biophys
1 BMC Health Serv Res
1 BMC Public Health
1 BMJ Case Rep
1 BMJ Glob Health
1 Cancer
1 Cancer Causes Control
1 Cancer Med
1 Cell Commun Signal
1 Clin Chim Acta
1 Clin Transl Radiat Oncol
1 Cureus
1 Eur Rev Med Pharmacol Sci
1 Expert Rev Anticancer Ther
1 FASEB Bioadv
1 Front Immunol
1 Front Public Health
1 Gen Physiol Biophys
1 Gynecol Oncol Rep
1 Hum Vaccin Immunother
1 Int Immunopharmacol
2 Int J Biol Macromol
1 Int J Gynaecol Obstet
1 Int J Gynecol Cancer
1 Int J Womens Health
1 J Appl Microbiol
2 J Cancer Res Ther
1 J Gynecol Obstet Hum Reprod
1 J Low Genit Tract Dis
1 J Mater Chem B
1 J Natl Cancer Inst
1 J Transl Med
1 Jpn J Radiol
1 Med Oncol
1 Menopause
1 Molecules
1 Naunyn Schmiedebergs Arch Pharmacol
1 Obstet Gynecol Int
1 Oncol Lett
1 PeerJ
1 PLOS Glob Public Health
1 Prev Med
1 Public Health
1 Rev Assoc Med Bras (1992)
4 Sci Rep
1 Scott Med J
1 Sheng Wu Gong Cheng Xue Bao


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Cytol

  1. DE OLIVEIRA RL, Valente ECA, Gadelha JGS, Witkin SS, et al
    Critical Evaluation of Pap Test Adherence to Routine Screening in Amazonas State, Brazil.
    Acta Cytol. 2025;69:144-153.
    PubMed         Abstract available

  2. KIMURA F, Ohshima K, Kanai R, Urata T, et al
    Image Quantification Analysis of Cytoplasmic Mucin and Interpretation of Mucin Color in Lobular Endocervical Glandular Hyperplasia.
    Acta Cytol. 2025;69:131-143.
    PubMed         Abstract available


    Acta Obstet Gynecol Scand

  3. BJURBERG M, Hellman K, Sall TA, Staf C, et al
    Validation of data quality in the Swedish quality register of gynecologic cancer for cervical cancer and vulvar cancer-a Swedish gynecologic cancer group (Swe-GCG) study.
    Acta Obstet Gynecol Scand. 2025 May 7. doi: 10.1111/aogs.15152.
    PubMed         Abstract available


    Ann Clin Lab Sci

  4. CAO L
    Multiple Lines of Treatment in a Patient with Small Cell Neuroendocrine Carcinoma of the Cervix: A Case Report.
    Ann Clin Lab Sci. 2025;55:286-292.
    PubMed         Abstract available


    Ann Epidemiol

  5. HUANG CS, Hsiao BY, Wu MH, Chiang CJ, et al
    Association Between Screening History and Prognosis of Cervical Carcinoma in Situ and Invasive Cervical Cancer: A Population-Based Cohort Study.
    Ann Epidemiol. 2025 May 3:S1047-2797(25)00089.
    PubMed         Abstract available


    Ann Rheum Dis

  6. SIDDIQI KZ, Baandrup L, Diederichsen L, Hertzum-Larsen R, et al
    Risk of HPV-associated precancer and cancer in women with systemic lupus erythematosus.
    Ann Rheum Dis. 2025;84:760-766.
    PubMed         Abstract available


    Apoptosis

  7. SUN X, Chen Z, Yang H, Yu J, et al
    Targeting ferroptosis for precision medicine in cervical cancer.
    Apoptosis. 2025 May 7. doi: 10.1007/s10495-025-02120.
    PubMed         Abstract available


    Arch Biochem Biophys

  8. GANESH GV, Balu G, Jayasuriya R, Ramkumar KM, et al
    Exosomal miR16 Induced by Allyl Isothiocyanate (AITC) Inhibits Tumor Growth in Cervical Cancer via Modulation of Apoptotic and Inflammatory Pathways.
    Arch Biochem Biophys. 2025 Apr 30:110446. doi: 10.1016/j.abb.2025.110446.
    PubMed         Abstract available


    BMC Health Serv Res

  9. BURROWES S, Seyoum Alemu H, Khokhar N, McMillian G, et al
    Coordinating under constraint: a qualitative study of communication and teamwork along Ethiopia's cervical cancer care continuum.
    BMC Health Serv Res. 2025;25:652.
    PubMed         Abstract available


    BMC Public Health

  10. NESSA A, Uddin SMN, Lucas E, Nag P, et al
    Implementation of an electronic health information system using DHIS2 tracker to manage and evaluate the National cervical screening programme in Bangladesh.
    BMC Public Health. 2025;25:1649.
    PubMed         Abstract available


    BMJ Case Rep

  11. CERQUEIRA L, Pinto PV, Bernardes J, Martinho M, et al
    Vaginal myomectomy of multiple cervical myomas.
    BMJ Case Rep. 2025;18:e264879.
    PubMed         Abstract available


    BMJ Glob Health

  12. CHOI H, Dion H, Huang M, Sathyan L, et al
    Applying the Information-Motivation-Behavioral Skills model to a video-assisted HPV intervention to promote self-screening uptake: a qualitative study in Western Kenya.
    BMJ Glob Health. 2025;10:e017616.
    PubMed         Abstract available


    Cancer

  13. HUANG CC, Ayala-Peacock DN, Stephens SJ, Chino JP, et al
    Recent advances in gynecologic radiation oncology.
    Cancer. 2025;131:e35888.
    PubMed         Abstract available


    Cancer Causes Control

  14. EKWUEME DU, Reagan KA, Kao SY, Dasari S, et al
    Estimated health outcomes of breast cancer screening in the national breast and cervical cancer early detection program by race/ethnicity.
    Cancer Causes Control. 2025 May 6. doi: 10.1007/s10552-025-02006.
    PubMed         Abstract available


    Cancer Med

  15. KANG Y, Chang L, Liu J, Ji H, et al
    Prognostic Differences and Survival Predictive Models for Mucinous Versus Usual-Type Adenocarcinoma of the Uterine Cervix.
    Cancer Med. 2025;14:e70927.
    PubMed         Abstract available


    Cell Commun Signal

  16. ESWARAN S, Mascarenhas R, Kabekkodu SP
    The ester derivative Palmitoylcarnitine abrogates cervical cancer cell survival by enhancing lipotoxicity and mitochondrial dysfunction.
    Cell Commun Signal. 2025;23:213.
    PubMed         Abstract available


    Clin Chim Acta

  17. DE SOUZA LEAO LQ, de Andrade JC, Marques GM, Guimaraes CC, et al
    Rapid prediction of cervical cancer and high-grade precursor lesions: An integrated approach using low-field (1)H NMR and chemometric analysis.
    Clin Chim Acta. 2025;574:120346.
    PubMed         Abstract available


    Clin Transl Radiat Oncol

  18. SITTIWONG W, Dankulchai P, Wongsuwan P, Prasartseree T, et al
    Pre-Treatment and Pre-Brachytherapy MRI first-order Radiomic Features by a Commercial software as survival predictors in radiotherapy for cervical cancer Objectives.
    Clin Transl Radiat Oncol. 2025;53:100965.
    PubMed         Abstract available


    Cureus

  19. GRIESMER K, Hadderton L, Bishop LR, Robinett DA, et al
    A Case of Hemorrhagic Shock From Newly Diagnosed Cervical Cancer.
    Cureus. 2025;17:e81793.
    PubMed         Abstract available


    Eur Rev Med Pharmacol Sci

  20. ZHANG YY, Li M, Xu YD, Shang J, et al
    Retraction Note: LncRNA SNHG14 promotes the development of cervical cancer and predicts poor prognosis.
    Eur Rev Med Pharmacol Sci. 2025;29:151.
    PubMed         Abstract available


    Expert Rev Anticancer Ther

  21. NANDI A, Ghosh A, Sil SK
    The interplay between angiogenesis and cervical cancer: a comprehensive review.
    Expert Rev Anticancer Ther. 2025 May 5. doi: 10.1080/14737140.2025.2501073.
    PubMed         Abstract available


    FASEB Bioadv

  22. CHEN G, Zheng Z, Ji Q, He R, et al
    Tumor innervation in cervical cancer: Prognostic insights from myelin-associated risk signatures.
    FASEB Bioadv. 2025;7:e70004.
    PubMed         Abstract available


    Front Immunol

  23. LI X, Deng J, Liu X, Zhou Y, et al
    Tissue-resident immune cells in cervical cancer: emerging roles and therapeutic implications.
    Front Immunol. 2025;16:1541950.
    PubMed         Abstract available


    Front Public Health

  24. XUE S, Zeng X, Li J, Kang L, et al
    Feasibility and acceptability of human papillomavirus self-sampling compared with clinician sampling in urban areas of western China: a cross-sectional survey.
    Front Public Health. 2025;13:1524796.
    PubMed         Abstract available


    Gen Physiol Biophys

  25. ZHENG J, Feng Y, Yuan C
    Hsa_circ_0007905 as a modulator of miR-330-5p and VDAC1: Enhancing stemness and reducing apoptosis in cervical cancer stem cells.
    Gen Physiol Biophys. 2025;44:213-226.
    PubMed         Abstract available


    Gynecol Oncol Rep

  26. BRAVO E, Cartagena J, Urbina C, Galdames L, et al
    Vaginal radical hysterectomy in early stage cervical cancer.
    Gynecol Oncol Rep. 2025;59:101744.
    PubMed         Abstract available


    Hum Vaccin Immunother

  27. AGHA S, Zeng W
    Cost-effectiveness of a behavioral insights-informed digital campaign to increase HPV vaccination in Bangladesh.
    Hum Vaccin Immunother. 2025;21:2500264.
    PubMed         Abstract available


    Int Immunopharmacol

  28. CHE Y, Song B, Song Y, Sun J, et al
    Thymoquinone enhances efficacy of cervical Cancer therapeutic vaccines via modulating CD8(+) T cells.
    Int Immunopharmacol. 2025 Apr 9:114605. doi: 10.1016/j.intimp.2025.114605.
    PubMed         Abstract available


    Int J Biol Macromol

  29. MAI Q, Du Q, Zeng F, Chen Y, et al
    Galectin-3 suppresses CD8(+) T cells function via myeloid-derived suppressor cells recruitment in cervical cancer.
    Int J Biol Macromol. 2025 May 1:143683. doi: 10.1016/j.ijbiomac.2025.143683.
    PubMed         Abstract available

  30. WANG S, Liu C, Ye D, Qi J, et al
    Deciphering the mechanism of baicalein in cervical cancer via bioinformatics, machine learning and computational simulations: PIM1 and CDK2 are key target proteins.
    Int J Biol Macromol. 2025 May 6:144014. doi: 10.1016/j.ijbiomac.2025.144014.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  31. ROMANISHIN A, Efimenko B, Katserov D, Agapov M, et al
    Comprehensive cross-sectional study of CIN prevalence, HPV genotyping, genetic alterations, and microbiota as molecular biomarkers for early cervical cancer detection: A pilot clinical study among women in Russia.
    Int J Gynaecol Obstet. 2025 May 5. doi: 10.1002/ijgo.70090.
    PubMed         Abstract available


    Int J Gynecol Cancer

  32. BIZZARRI N, Querleu D, Ramirez PT, Plante M, et al
    Minimally invasive simple hysterectomy in low-risk cervical cancer: a single-arm trial with stopping rules (ENGOT-cx23/MITO/LASH trial).
    Int J Gynecol Cancer. 2025;35:101818.
    PubMed         Abstract available


    Int J Womens Health

  33. WANG W, Zhang Y
    Analysis of the Predictive Efficacy and Influencing Factors of Serum Tie-1, FoxO3a, and PKD1 for Lymph Node Metastasis in Cervical Cancer.
    Int J Womens Health. 2025;17:1215-1224.
    PubMed         Abstract available


    J Appl Microbiol

  34. SHIBATA T, Ohno A, Murakami I, Takakura M, et al
    Effect of chemical peeling therapy for treatment of cervical intraepithelial neoplasia on cervicovaginal microbiota.
    J Appl Microbiol. 2025;136:lxaf080.
    PubMed         Abstract available


    J Cancer Res Ther

  35. KE X, Zang C, Wu A, Liu Y, et al
    Predicting the incidence of hematologic toxicity in concurrent chemoradiotherapy for cervical cancer using pelvic MRI imaging.
    J Cancer Res Ther. 2025;21:354-361.
    PubMed         Abstract available

  36. ZHENG Z, Liu D, Su Y
    Supine/prone position fixation treatment in cervical cancer radiotherapy.
    J Cancer Res Ther. 2025;21:401-408.
    PubMed         Abstract available


    J Gynecol Obstet Hum Reprod

  37. LENOIR P, Guillet J, Desmarets M, Baraquin A, et al
    Human papillomavirus genotype distribution among high-grade cervical lesions in French women born between 1972 and 1993.
    J Gynecol Obstet Hum Reprod. 2025;54:102945.
    PubMed         Abstract available


    J Low Genit Tract Dis

  38. LAVECCHIA M, Selk A, Marcucci M, Nica A, et al
    Lifetime Cervical Cancer Screening and Social Determinants of Health in the Canadian Longitudinal Study on Aging.
    J Low Genit Tract Dis. 2025 May 2. doi: 10.1097/LGT.0000000000000895.
    PubMed         Abstract available


    J Mater Chem B

  39. GU D, Liang X, Shao Z, He H, et al
    A cascaded amplification carrier-free nanoplatform for synergistic photothermal/ferroptosis therapy via dual antioxidant pathway disruption in cervical cancer.
    J Mater Chem B. 2025 May 8. doi: 10.1039/d5tb00627.
    PubMed         Abstract available


    J Natl Cancer Inst

  40. WHEELER CM, Adcock R, Hunt WC, Robertson M, et al
    HPV genotype-specific prevalence and infection risks: A 10-year population-based study from the United States.
    J Natl Cancer Inst. 2024 Dec 10:djae327. doi: 10.1093.
    PubMed         Abstract available


    J Transl Med

  41. ZHAO L, Chen X, Zhang Y, Cen Y, et al
    The biomarker potential of circPOLD1 and its binding protein YBX1 in cervical carcinogenesis.
    J Transl Med. 2025;23:506.
    PubMed         Abstract available


    Jpn J Radiol

  42. HIMOTO Y, Kido A, Yamanoi K, Kurata Y, et al
    Limited diagnostic performance of imaging evaluation for staging in gastric-type endocervical adenocarcinoma: a multi-center study.
    Jpn J Radiol. 2025;43:810-819.
    PubMed         Abstract available


    Med Oncol

  43. RAGHANI NR, Chorawala MR, Parekh K, Sharma A, et al
    Exosomal miRNA-based theranostics in cervical cancer: bridging diagnostics and therapy.
    Med Oncol. 2025;42:193.
    PubMed         Abstract available


    Menopause

  44. ZHOU Q, Li T, Zhu L, Chang Y, et al
    The clinical performance of different cervical cancer screening strategies in premenopausal and postmenopausal women.
    Menopause. 2025 May 6. doi: 10.1097/GME.0000000000002546.
    PubMed         Abstract available


    Molecules

  45. LI Y, Liu T, Pan G, Li Y, et al
    Orychophragvioline A, a Novel Alkaloid Isolated from Orychophragmus violaceus with Anti-Cervical Cancer Activity.
    Molecules. 2025;30:1759.
    PubMed         Abstract available


    Naunyn Schmiedebergs Arch Pharmacol

  46. XIANG H, Sun J, Kong L, Wang Y, et al
    NDUFA8 promotes cell viability and inhibits ferroptosis and cisplatin sensitivity by stabilizing Fe-S clusters in cervical cancer.
    Naunyn Schmiedebergs Arch Pharmacol. 2025 May 8. doi: 10.1007/s00210-025-04237.
    PubMed         Abstract available


    Obstet Gynecol Int

  47. ALDARIZ-AMAYA R, Rodriguez-Esquivel M, Ruiz-Romero A, Anthor F, et al
    Innovative Noninvasive HPV Screening Using a Feminine Pad: A Pilot Study for Enhanced Cervical Cancer Detection.
    Obstet Gynecol Int. 2025;2025:9344596.
    PubMed         Abstract available


    Oncol Lett

  48. TOKALIOGLU AA, Oktar O, Aytekin O, Alci A, et al
    Intermediate?risk factors affecting oncological outcome in patients with FIGO 2018 stage IB2 cervical cancer who do not receive adjuvant therapy.
    Oncol Lett. 2025;29:308.
    PubMed         Abstract available


    PeerJ

  49. WU X, Xu C, Zhang X, Qu Q, et al
    Preoperative prediction of p16 expression in cervical cancer by amide proton transfer imaging combined with diffusion kurtosis imaging: a retrospective study.
    PeerJ. 2025;13:e19387.
    PubMed         Abstract available


    PLOS Glob Public Health

  50. OLIVIERI DJ, Eastment MC, Mugisha N, Menon MP, et al
    Correlates of cervical cancer awareness among women aged 30-49 in five sub-Saharan African nations: Evidence from the Demographic and Health Survey (DHS)-2017-2023.
    PLOS Glob Public Health. 2025;5:e0003344.
    PubMed         Abstract available


    Prev Med

  51. RING LL, Lindquist S, Rosthoj S, Larsen HK, et al
    Prevalence of cervical human papillomavirus in kidney transplant recipients: A systematic review and meta-analysis.
    Prev Med. 2024;182:107927.
    PubMed         Abstract available


    Public Health

  52. GOMES MLS, Cestari VRF, Florencio RS, Yamamura M, et al
    Spatial-temporal analysis of cervical cancer screening and social and health indicators in Brazil.
    Public Health. 2025;243:105747.
    PubMed         Abstract available


    Rev Assoc Med Bras (1992)

  53. FREIRE GS, Amaral CLR, Romano JJ, Bussamra Aulicino C, et al
    Human papillomavirus vaccination: if the vaccine is important and available, why not use it?
    Rev Assoc Med Bras (1992). 2025;71:e20240865.
    PubMed         Abstract available


    Sci Rep

  54. MISHRA SK, Shaheen MM, Sultana S, Al-Dies AM, et al
    Computational analysis of lupenone derivatives as potential inhibitor of human papillomavirus oncoprotein E6 associated cervical cancer.
    Sci Rep. 2025;15:15402.
    PubMed         Abstract available

  55. LI J, Wu T, Cai M, Xie C, et al
    Prognostic analysis of nimotuzumab combined with concurrent chemoradiotherapy for locally advanced cervical cancer: a multicenter real-world study.
    Sci Rep. 2025;15:15877.
    PubMed         Abstract available

  56. SU S, Yang B, Liu H, Yin W, et al
    Four genes shared between rheumatoid arthritis and cervical cancer are associated with cervical cancer prognosis.
    Sci Rep. 2025;15:15884.
    PubMed         Abstract available

  57. ZHU F, Li L, Zhang H, Liu J, et al
    Dynamic causal effects of gut microbiota on cervical Cancer lesion progression.
    Sci Rep. 2025;15:15490.
    PubMed         Abstract available


    Scott Med J

  58. RAGUPATHY K, McMullen W
    Cervical cancer prevention - interventions to improve screening.
    Scott Med J. 2025;70:25-26.
    PubMed        


    Sheng Wu Gong Cheng Xue Bao

  59. XU H, Li S, Luo X, Zhou Z, et al
    [Oncolytic virus-mediated base editing for targeted killing of cervical cancer cells].
    Sheng Wu Gong Cheng Xue Bao. 2025;41:1382-1394.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.